FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q91607455> ?p ?o ?g. }

• Q91607455 description "article scientifique publié en 2019" @default.
• Q91607455 description "artículu científicu espublizáu en payares de 2019" @default.
• Q91607455 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
• Q91607455 description "scientific article published on 29 November 2019" @default.
• Q91607455 description "wetenschappelijk artikel" @default.
• Q91607455 description "наукова стаття, опублікована 29 листопада 2019" @default.
• Q91607455 name "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 name "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 type Item @default.
• Q91607455 label "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 label "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 prefLabel "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 prefLabel "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 P1433 Q91607455-27027C8A-18EB-4E07-A786-F04E3261A160 @default.
• Q91607455 P1476 Q91607455-44070EDB-1D48-4056-BA18-7E37D78829F7 @default.
• Q91607455 P2093 Q91607455-A230E01C-3202-4836-ADBE-5236F83A687B @default.
• Q91607455 P2093 Q91607455-CFB030D0-21E9-4DF5-ADEE-2374A8995BD5 @default.
• Q91607455 P2093 Q91607455-D2B0C9AC-E648-4920-9D85-1312822C622C @default.
• Q91607455 P304 Q91607455-836ABD03-4C51-4E41-8D1B-1C0CA60B471F @default.
• Q91607455 P31 Q91607455-9636E0EE-48A1-47CD-BB80-865051A77033 @default.
• Q91607455 P356 Q91607455-F74C5158-B90C-419E-BEFB-8E8D91513E39 @default.
• Q91607455 P478 Q91607455-265F83E6-B0E0-4958-90EA-B01A40EEDEC7 @default.
• Q91607455 P577 Q91607455-AED456C6-48FB-45F3-ADA3-CDF04093C12D @default.
• Q91607455 P698 Q91607455-ABD018CC-CA94-4897-A1F8-0811FC297B32 @default.
• Q91607455 P921 Q91607455-184A84E0-AB13-43D9-83B2-AD5F72796B84 @default.
• Q91607455 P356 J.IJPHARM.2019.118886 @default.
• Q91607455 P698 31790804 @default.
• Q91607455 P1433 Q6051539 @default.
• Q91607455 P1476 "Nanoparticle formulations as recrystallization inhibitors in transdermal patches" @default.
• Q91607455 P2093 "Alf Lamprecht" @default.
• Q91607455 P2093 "Mohamed Ehab Ali" @default.
• Q91607455 P2093 "Muhammad Azam Tahir" @default.
• Q91607455 P304 "118886" @default.
• Q91607455 P31 Q13442814 @default.
• Q91607455 P356 "10.1016/J.IJPHARM.2019.118886" @default.
• Q91607455 P478 "575" @default.
• Q91607455 P577 "2019-11-29T00:00:00Z" @default.
• Q91607455 P698 "31790804" @default.
• Q91607455 P921 Q61231 @default.